国立衛生研究所は,静脈性血栓栓塞栓症の研究に資金を提供している
Ryan A Coute1, Jake Toy2, Kameshwari Soundararajan3
1Department of Emergency Medicine, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL.
Journal of thrombosis and haemostasis : JTH
|February 15, 2026
まとめ
静脈血栓塞栓症 (VTE) 研究のための国立衛生研究所 (NIH) の資金は増加したが,心臓病や脳卒中と比較して依然として低い. この分析は,その重大な死亡負担と闘うために,VTE研究への投資の増加の必要性を強調しています.
科学分野:
- 生物医学研究資金の分析 分析
- 血管の健康に関する研究
- 公共衛生政策 公共衛生政策
背景:
- 静脈血栓栓塞栓症 (VTE) は,米国で毎年約10万人の死亡の原因となっています.
- 研究資金は,VTEの予防,診断,治療,回復を進めるために不可欠です.
- 国立衛生研究所 (NIH) は,特定のVTE資金の報告をしていないため,進歩を妨げています.
研究 の 目的:
- 過去10年 (2015年-2024年) のVTE研究に対するNIHの資金提供傾向を記述的に分析する.
- VTEの研究費を他の主要な血管疾患の研究費と比較する.
主な方法:
- VTEに関連する用語を使用して,NIH RePORTERデータベース (2015-2024) で検索しました.
- 大型言語モデルを用いたVTE研究として分類された助成金.
- 資金調達額,助成金数,主要調査員を分析し,2023年のVTE資金調達を心臓病と脳卒中と比較した.
主要な成果:
- 合計2,130の助成金のうち,1,114のVTE研究助成金を特定しました.
- VTE研究のためのインフレ調整されたNIH資金は,2015年の4200万ドルから2024年の6710万ドルに増加し,2021年には7300万ドルのピークに達しました.
- 2023年,NIHの死亡あたりの資金は,心臓病 (2,765ドル) と脳卒中 (2,724ドル) と比較して,VTE (639ドル) に対して大幅に低かった.
結論:
- VTE研究へのNIHの投資は,過去10年間で増加しています.
- VTEの研究資金は,他の血管疾患と比較して,その重大な死亡率への影響に照らして,不均衡に低いままです.
- VTEによる重大な公衆衛生上の負担に対処するために,資金の増大が必要である.
関連する概念動画
Varicose Veins II: Diagnostic Studies and Interprofessional Care
326
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
326
Venous Thrombosis I: Introduction
834
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
834
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
470
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
470
Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Venous Thrombosis IV: Nursing Management
418
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
418
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
764
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
764


